📰 Complete Response News
Page 6 - Complete Response News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Complete Response. Real-time updates on events, politics, business and more.
May 22, 2023
Expert Elias Jabbour, MD, reviews clinical data from the PhALLCON study of ponatinib vs imatinib in patients with Ph+ acute lymphocytic leukemia and considers its clinical implications.
May 10, 2023
Theralase Provides Update on Phase II Bladder Cancer Study
May 10, 2023
Experts on skin cancer discuss valuable end points for determining successful treatments for patients with metastatic melanoma.
May 10, 2023
– Positive Phase 1 clinical data presented for PRGN-2012 AdenoVerse™ immunotherapy in RRP demonstrated favorable safety profile and significant reduction in...
April 26, 2023
TORONTO, April 26, 2023 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage...
April 3, 2023
In the wake of the Department of Health and Human Services' (HHS) February announcement that they will be discontinuing the COVID-19 public health emergency (PHE) declaration on May 11, 2023...
March 30, 2023
PETACH TIKVA, Israel--(BUSINESS WIRE)--Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory
March 30, 2023
With maximum limits for Occupational Safety and Health Administration (OSHA) penalties increasing every year – currently over $15,000 for serious/other than serious citations and more...
March 30, 2023
Announces strategic reprioritization to focus on clinical development of MT-6402, MT-8421, and MT-0169, and preclinical activities related to BMS...
March 30, 2023
31.03.2023 - Announces strategic reprioritization to focus on clinical development of MT-6402, MT-8421, and MT-0169, and preclinical activities related to BMS collaboration, and related workforce reductionAUSTIN, Texas, March 30, 2023 (GLOBE NEWSWIRE) - ...